Cc1ccc(C)c(NC(=O)CN(C)C(=O)[C@@H](NC(=O)c2ccc(C(C)(C)C)cc2)C(C)C)c1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?